1257214-56-4

Basic information

• Product Name: N-[1-(4-bromo-phenyl)-cyclopropanecarbonyl]-methanesulfonamide
• Synonyms: N-[1-(4-bromo-phenyl)-cyclopropanecarbonyl]-methanesulfonamide
• CAS NO: 1257214-56-4
• Molecular Weight: 318.191
• Mol File: 1257214-56-4.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: N-[1-(4-bromo-phenyl)-cyclopropanecarbonyl]-methanesulfonamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-[1-(4-bromo-phenyl)-cyclopropanecarbonyl]-methanesulfonamide(1257214-56-4)
• EPA Substance Registry System: N-[1-(4-bromo-phenyl)-cyclopropanecarbonyl]-methanesulfonamide(1257214-56-4)

Safety Data

• Hazardous Substances Data: 1257214-56-4(Hazardous Substances Data)

Upstream product

• 3144-09-0 methanesulfonamide 
• 345965-52-8 1-(4-bromophenyl)cyclopropanecarboxylic acid 
• 124276-67-1 1-(4-bromophenyl)cyclopropanecarbonitrile 
• 16532-79-9 4-Bromophenylacetonitrile 

Downstream Products

• 1257214-59-7 N-{1-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-cyclopropanecarbonyl}-methanesulfonamide 
• 1284212-22-1 N-[1-(4'-{4-[(5-Benzyl-[1,3,4]oxadiazol-2-yl)-hydroxy-methyl]-3-methyl-isoxazol-5-yl}-biphenyl-4-yl)-cyclopropanecarbonyl]-methanesulfonamide 
• 1396007-52-5 {3-[4'-(1-methanesulfonylaminocarbonyl-cyclopropyl)-biphenyl-4-yl]-5-methyl-3H-[1,2,3]triazol-4-yl}-carbamic acid (R)-1-phenyl-ethyl ester 
• 1396007-78-5 {5-[4'-(1-methanesulfonylaminocarbonyl-cyclopropyl)biphenyl-4-yl]-3-methyl-3H-[1,2,3]triazol-4-yl}carbamic acid (R)-1-phenyl-ethyl ester 
• 1396007-80-9 {5-[4'-(1-methanesulfonylaminocarbonyl-cyclopropyl)biphenyl-4-yl]-3-methyl-3H-[1,2,3]triazol-4-yl}carbamic acid (R)-1-(3-trifluoromethylphenyl)ethyl ester 

Relevant articles and documents

N-ALKYLTRIAZOLE COMPOUNDS AS LPAR ANTAGONISTS

Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful

LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS

Described herein are compounds that are antagonists of lysophosphatidic receptor(s). Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such antagonists, alone and in com

POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS

Described herein are compounds that are antagonists of lysophosphatidic receptor(s). Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such antagonists, alone and in combination with other compounds, for treating LPA-dependent or LPA-mediated conditions or diseases.